The overexpression of RB1CC1 decreased the phosphorylation of PyK2 and doxorubicin, which increased RB1CC1 expression and reduced the size of xenografted renal cell carcinoma tumors [99]. This evidence concerns the gene RB1CC1 and renal cell carcinoma.